204 related articles for article (PubMed ID: 27528092)
21. Interleukin-11 induces the expression of matrix metalloproteinase 13 in gastric cancer SCH cells partly via the PI3K-AKT and JAK-STAT3 pathways.
Yang G; Ma F; Zhong M; Fang L; Peng Y; Xin X; Zhong J; Zhu W; Zhang Y
Mol Med Rep; 2014 Apr; 9(4):1371-5. PubMed ID: 24504547
[TBL] [Abstract][Full Text] [Related]
22. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
23. The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway.
Jiang Y; Feng YP; Tang LX; Yan YL; Bai JW
Biochem Biophys Res Commun; 2019 Oct; 517(4):697-702. PubMed ID: 31399192
[TBL] [Abstract][Full Text] [Related]
24. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
25. GSK3B Overexpression Alleviates Posttraumatic Osteoarthritis in Mice by Promoting DNMT1-Mediated Hypermethylation of NR4A3 Promoter.
Lv Z; Sun D; Li X; Wu G
Dis Markers; 2022; 2022():4185489. PubMed ID: 35747513
[TBL] [Abstract][Full Text] [Related]
26. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
28. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer.
Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ
Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752
[TBL] [Abstract][Full Text] [Related]
29. [Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines].
Yu LF; Zhu YB; Qiao MM; Zhong J; Tu SP; Wu YL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2064-9. PubMed ID: 15730617
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
32. NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Deutsch AJA; Rinner B; Pichler M; Prochazka K; Pansy K; Bischof M; Fechter K; Hatzl S; Feichtinger J; Wenzl K; Frisch MT; Stiegelbauer V; Prokesch A; Krogsdam A; Sill H; Thallinger GG; Greinix HT; Wang C; Beham-Schmid C; Neumeister P
Cancer Res; 2017 May; 77(9):2375-2386. PubMed ID: 28249906
[TBL] [Abstract][Full Text] [Related]
33. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
34. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
35. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
[TBL] [Abstract][Full Text] [Related]
36. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
37. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract][Full Text] [Related]
38. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
39. Transfection of HCVc improves hTERT expression through STAT3 pathway by epigenetic regulation in Huh7 cells.
Guo N; Cheng D; Li ZH; Zhou QB; Zhou JJ; Lin Q; Zeng B; Liao Q; Chen RF
J Cell Biochem; 2012 Nov; 113(11):3419-26. PubMed ID: 22688977
[TBL] [Abstract][Full Text] [Related]
40. Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer.
Zhu J; Deng L; Chen B; Huang W; Lin X; Chen G; Tzeng CM; Ying M; Lu Z
Curr Cancer Drug Targets; 2019; 19(10):817-827. PubMed ID: 31218958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]